mRNA-1365 (Profile 2) clinical trials

A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults

This study is testing new vaccine candidates, called mRNA-1365 and mRNA-1345, for illnesses like Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV). Researchers want to see if these vaccines are safe, what side effects they might cause, and how well they help older healthy adults' immune systems fight off these viruses.